![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 16/40 | |
C12Q 1/68 | |||
A61K 39/00 | |||
C12Q 1/6883 |
(11) | Number of the document | 3004172 |
(13) | Kind of document | T |
(96) | European patent application number | 14739600.6 |
Date of filing the European patent application | 2014-05-29 | |
(97) | Date of publication of the European application | 2016-04-13 |
(45) | Date of publication and mention of the grant of the patent | 2019-11-27 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2014/040050 |
Date | 2014-05-29 |
(87) | Number | WO 2014/194111 |
Date | 2014-12-04 |
(30) | Number | Date | Country code |
201361828730 P | 2013-05-30 | US | |
201361889553 P | 2013-10-11 | US | |
201361901212 P | 2013-11-07 | US |
(72) |
SWERGOLD, Gary, US
MELLIS, Scott, US
SASIELA, William, J., US
|
(73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
(54) | METHODS FOR TREATING AUTOSOMAL DOMINANT HYPERCHOLESTEROLEMIA ASSOCIATED WITH PCSK9 GAIN-OF-FUNCTION MUTATIONS |
METHODS FOR TREATING AUTOSOMAL DOMINANT HYPERCHOLESTEROLEMIA ASSOCIATED WITH PCSK9 GAIN-OF-FUNCTION MUTATIONS |